Hyospan

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hyospan

Property Description
Active ingredient Hyoscine Butylbromide
Form Tablet, Solution for Injection, Syrup, Suppository
Pharmacological class Anticholinergic, Antispasmodic
Common use Relief of painful smooth muscle spasms
Origin Semisynthetic derivative (Quaternary Ammonium Compound)

Active Ingredient: Hyoscine Butylbromide and its Origin

Hyospan is a medicine specifically designed to relieve painful cramping and spasms in internal organs. The single active ingredient is Hyoscine Butylbromide, a substance also known as Scopolamine Butylbromide. This compound is a semisynthetic derivative, chemically synthesized from the naturally occurring tropane alkaloid scopolamine. Hyoscine Butylbromide is defined as a quaternary ammonium compound, a distinct molecular structure that significantly restricts its ability to cross the blood-brain barrier. This structural feature is crucial, as it limits the medicine’s activity primarily to the body’s periphery, focusing the therapeutic effect on the target organs and minimizing the risk of central neurological effects often associated with older anticholinergics.

Classification and General Purpose

Hyoscine Butylbromide is classified as an anticholinergic agent, operating within the therapeutic category of antispasmodics. The medicine exerts its spasmolytic action by acting as an antagonist at the muscarinic acetylcholine receptors on the smooth muscle cells lining the gastrointestinal tract, the biliary tract, and the genito-urinary tract. The primary general purpose is the direct reduction and relief of the sharp, sudden pain resulting from smooth muscle spasm or hyperactivity in the abdominal and pelvic area. The focused action of this agent is recognized for providing effective relief from acute abdominal pain caused by spasms. The drug is supplied in multiple dosage forms, including the common oral tablet and a sterile solution for injection, offering versatility for routine management or immediate intervention.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Hyospan?

Possible Side Effects and Safety Information

The safety profile for Hyoscine Butylbromide is defined by its anticholinergic properties, which are documented in official regulatory classifications. The most frequently reported adverse effects often relate to its action on peripheral smooth muscle and glands, and these are typically classified as Common in regulatory documents.

Official Side Effect Classifications

Side effects are categorized by the physiological system affected (System Organ Class) and their frequency of occurrence, based on regulatory standards:

  • Common Reactions (1/100 to < 1/10): This category includes dry mouth, tachycardia (increased heart rate), and accommodation disorders (difficulty focusing the eyes).
  • Rare Reactions (1/10,000 to < 1/1,000): This frequency band includes events such as urinary retention.
  • System Classes: Officially documented effects include those on the Gastrointestinal system, Cardiac system, Eye system, Skin and Subcutaneous Tissue, and Renal and Urinary system.

Serious Adverse Reactions and Safety Constraints

Official labeling describes a risk of severe reactions, although these are typically reported as Not Known (frequency cannot be estimated from clinical data). These include life-threatening Anaphylactic Shock and other severe hypersensitivity events, particularly following injection. Serious Cardiac Adverse Reactions (e.g., hypotension, severe tachycardia) are noted as a risk, especially for patients with pre-existing cardiac disease.

Specific safety constraints are noted in regulatory information. The medicine is restricted in the presence of certain conditions that may be aggravated by reduced smooth muscle activity or its anticholinergic effect, such as narrow-angle glaucoma, a predisposition to urinary retention, or unexplained acute abdominal pain that persists or worsens. Furthermore, official labeling advises that effects like accommodation disorders may impact the ability to operate machinery.

Overdose and Emergency Response

If you suspect an overdose of Hyospan (hyoscine butylbromide), you must seek immediate medical attention. Overdose symptoms are primarily related to the drug's anticholinergic effects and require urgent professional assessment.

Documented Overdose Symptoms

Signs of taking too much Hyospan may include a cluster of anticholinergic effects, which can present as:

  • Cardiovascular: Tachycardia (fast heart rate).
  • Gastrointestinal/Genitourinary: Dry mouth, urinary retention (difficulty passing urine), and inhibition of gastrointestinal tract movement.
  • Vision/Eyes: Transient visual disturbances or blurred vision.
  • Skin: Reddening of the skin.
  • Other: Drowsiness and, in rare instances, Cheyne-Stokes respiration (an abnormal breathing pattern).

When to Seek Urgent Help

Seek immediate medical attention if you experience any signs of overdose. For individuals with underlying cardiac conditions (such as heart failure or coronary heart disease), adverse effects like tachycardia and hypotension can be serious and potentially severe, requiring careful monitoring. Emergency treatment for overdose is guided by the presenting symptoms and may involve specific measures such as administration of parasympathomimetic agents, catheterisation for urinary retention, or supportive care for respiratory issues.

Always inform healthcare professionals immediately if you believe too much medication was given, even if no symptoms are immediately apparent.

Therapeutic Uses of Hyospan

Quick Facts

  • Irritable Bowel Syndrome (IBS): May offer symptomatic relief from spasms and associated abdominal discomfort.
  • Spasm Relief: Indicated for the management of spasm in the gastrointestinal and genito-urinary tracts.
  • Colic: May be used in the symptomatic relief of renal and biliary colic.
  • Functional GI Conditions: May help to manage symptoms of hypermotility in functional intestinal disorders.

What Hyospan Treats: Main Uses and Benefits

Hyospan is a medication used to help manage symptoms associated with various conditions of the gastrointestinal, genito-urinary, and biliary tracts. Its primary role is to provide symptomatic relief by addressing issues of smooth muscle spasm and hypermotility in these areas.

Specifically, Hyospan may be used to address the abdominal pain, discomfort, and cramps that are linked to disorders such as irritable bowel syndrome (IBS). It can be employed as part of an overall treatment plan for functional intestinal disorders to assist in controlling visceral spasm and hypermotility. The medication also plays a role in the symptomatic management of pain associated with biliary colic (gallstone-related pain) and renal colic (kidney stone-related pain).

It is important to note that Hyospan is an adjunctive therapy, meaning it is used alongside other management strategies to help control symptoms rather than curing the underlying condition.

Eligibility and Restrictions for Use

Contraindications (Must Not Use)

Hyospan is strictly contraindicated for use in populations with specific pre-existing conditions as defined by regulatory documents. These include:

  • Myasthenia Gravis
  • Untreated Narrow-Angle Glaucoma
  • Mechanical obstructions of the gastrointestinal tract, such as Paralytic or Obstructive Ileus and Megacolon
  • Prostatic Hypertrophy with urinary retention
  • Known Hypersensitivity to the active substance or excipients

Age and Physiological Restrictions

Use is generally approved for adults and children aged 6 years and older. The oral tablets are officially not recommended for children under 6 years of age.

Due to insufficient human data, Hyospan is officially not recommended for use during pregnancy or lactation as a precautionary measure.


Conditional Use and Route Restrictions

Caution is advised for patients with certain pre-existing cardiac conditions and those prone to tachyarrhythmias. Caution is also noted for individuals with existing hepatic or renal impairment.

A route-specific restriction exists: the injection is contraindicated for intramuscular administration in patients receiving anticoagulant drugs.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Hyoscine Butylbromide (Hyospan) documents several interaction patterns, primarily stemming from its pharmacodynamic properties. The co-administration of Hyospan with other medicines possessing anticholinergic properties (such as tricyclic and tetracyclic antidepressants, certain antipsychotics like phenothiazines, quinidine, and H-1 antihistamines) may lead to an intensification or enhancement of the anticholinergic effect of both drugs.

Conversely, co-administration with Dopamine Antagonists (e.g., Metoclopramide) may result in a diminution of the effects of both medicines on gastrointestinal motility due to opposing actions. The label also notes that the tachycardic effects of Beta-adrenergic Agents may be enhanced.

A critical, administration-route-specific restriction is documented: the Intramuscular (IM) injection route is strictly prohibited for patients who are simultaneously receiving anticoagulant drugs (e.g., Warfarin). This procedural constraint is in place due to the documented risk of forming a local intramuscular haematoma. Furthermore, official guidance states that alcohol must be abstained from because it may increase the chance of side effects, such as drowsiness. Regarding administration timing, some regulatory information advises that this medicine should be taken at least one hour before antacids.

Mechanism of Action

How Hyospan Works

Hyospan (hyoscine butylbromide) functions as an anticholinergic agent, primarily engaging muscarinic receptors within the peripheral nervous system. This activity is restricted to peripheral action due to the drug's quaternary ammonium structure.

Antimuscarinic Receptor Blockade

Hyospan acts as a non-selective competitive antagonist by binding with high affinity to muscarinic acetylcholine receptors (M1, M2, and M3 subtypes) located on the surface of smooth muscle cells and exocrine glands. This engagement inhibits the action of the neurotransmitter acetylcholine, which is the primary signaling mediator for parasympathetic activity.

Physiological Modulation

The competitive blockade suppresses the signaling cascade that typically leads to smooth muscle contraction in the gastrointestinal, biliary, and genito-urinary tracts, resulting in the inhibition of muscle contraction (spasmolytic effect). Simultaneously, this action prevents acetylcholine from stimulating receptor-mediated glandular signaling, which results in the modulation of exocrine gland activity.

Dosage and Administration Information

How Hyospan is Used

Hyoscine Butylbromide (Hyospan) is administered through distinct routes depending on the clinical context. For routine management, the medicine is used via the oral route as 10 mg tablets. For acute episodes requiring rapid onset, it is administered parenterally via intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection.


Dosage and Frequency

The standard adult oral dosage for general spasm relief is 20 mg, administered up to four times daily. For symptoms of Irritable Bowel Syndrome, the oral regimen begins at 10 mg three times daily, which may be increased to a maximum of 20 mg four times daily. For acute parenteral administration, the dose is 20 mg to 40 mg, with the total cumulative daily dose across all parenteral routes restricted to 100 mg. Children aged 6 to 12 years are dosed at 10 mg of the oral tablet three times daily.


Administration Conditions and Duration

The oral tablets must be swallowed whole with water and should not be crushed, broken, or chewed. The use of the solution for injection requires specific procedural conditions: the intravenous dose must be administered slowly, and the intramuscular route should be avoided in patients receiving anticoagulant drugs. This medicine is intended for short-term or intermittent use; continuous daily administration is restricted unless the cause of the abdominal pain has been medically investigated.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hyospan

The following is an overview of the research evidence and study landscape for Hyoscine Butylbromide (Hyospan), based on formal regulatory and peer-reviewed scientific literature. This summary describes what was studied, what patterns the research highlights, and where the current evidence remains limited.


Evidence for Functional Abdominal Cramping and Irritable Bowel Syndrome (IBS)

Research has primarily examined this medication in adult populations experiencing conditions characterized by fluctuating or episodic manifestations of abdominal pain. The evidence base includes many short-term Randomized Controlled Trials (RCTs) that compare the medication to an inactive treatment (placebo). These studies typically use the oral tablet form and focus on outcomes related to physical discomfort, measuring changes in abdominal pain intensity using validated patient-reported scales. Findings describe patterns observed in these studies, where trials reported patterns of change in measured pain scores when compared to placebo.


Evidence for Acute Spasm in Biliary and Renal Colic

For the management of sudden, severe acute episodes of spasm, such as those associated with biliary or renal colic, research mainly examined the injection formulation. Comparative RCTs were conducted where the medication was evaluated in adult patients, either alone or as an adjunct to standard pain treatments. The studies explored outcomes related to systemic or functional imbalance, such as the patient's pain score reduction at 30 to 60 minutes, and the total amount of rescue pain medication required. Comparative trials studied different patterns of sustained pain scores against other pain treatments.


Primary Research Gaps and Uncertainties

A key limitation across the research landscape is that for chronic conditions characterized by fluctuating or episodic manifestations, the follow-up durations were limited in many key studies. This means the overall certainty remains low concerning long-term use. For acute pain, comparative evidence is lacking in some contexts, and evidence quality varies across studies when it is used as an adjunct. Pivotal research was conducted primarily in the general adult population, and data for certain groups remain insufficient, particularly in pediatric patients.

Key Studies & References

  1. Hyoscine butylbromide versus acetaminophen for nonspecific colicky abdominal pain in children: a randomized controlled trial
  2. A Comprehensive Review of the Effects of Hyoscine Butylbromide in Childhood

Frequently Asked Questions (FAQ)

Common questions about Hyospan (FAQ)

Q: Is Hyospan the same as Buscopan?

A: Yes, Hyospan contains the active ingredient hyoscine butylbromide. This is the same single active ingredient that is found in the commonly known brand-name medicine, Buscopan. Because they share the same active ingredient, they belong to the same pharmacological class.


Q: What is the difference between Hyospan and ibuprofen?

A: These two medicines work in different ways to relieve discomfort. Official product information describes Hyospan as an antispasmodic that works by relaxing the smooth muscles in the gut. Ibuprofen, however, is classified as a non-steroidal anti-inflammatory drug (NSAID) that reduces inflammation and general pain signals.


Q: Is Hyospan a controlled substance?

A: Hyospan (hyoscine butylbromide) is generally classified as an antispasmodic medicine. According to official drug scheduling and classification authorities, it is not typically listed as a controlled substance in major regulatory markets.


Q: How long does it usually take for Hyospan to start working?

A: For the oral tablets, some regulatory information indicates that the medicine typically begins to work quickly. Painful muscle cramps may begin to ease, with some regulatory information indicating onset within approximately 15 minutes.


Q: Can I drive after taking Hyospan?

A: Official labeling advises against driving or operating heavy machinery if certain side effects are experienced. Since the medicine may cause effects such as blurred vision or difficulty focusing the eyes (accommodation disorders), individuals should wait until their vision has fully returned to normal.


Q: Is it normal to have a dry mouth when taking Hyospan?

A: Yes, regulatory documents list dry mouth as a common side effect of this medicine. This means it may affect up to 1 in 10 people who use Hyospan.


Q: Can Hyospan cause blurred vision?

A: Official regulatory documents confirm that Hyospan can cause accommodation disorders, which is the medical term for difficulty focusing the eyes. This effect is often described by patients as blurred vision and is listed as a common side effect.


Q: Is Hyospan commonly prescribed for bladder spasms?

A: The official indications include the relief of spasms in the genito-urinary tract. This is the anatomical location relevant to the type of muscle activity involved in bladder spasms.


Q: Is Hyospan ever used in children?

A: Yes, official labeling indicates that the oral tablet form of Hyospan is approved for use in adults and children aged 6 years and older. However, it is not recommended for children under 6 years of age.


Q: Can older adults use Hyospan safely?

A: Hyospan has been included in clinical trials involving patients over the age of 65. Official regulatory information states that no adverse reactions specific to the elderly age group have been noted or reported in the product’s safety profile.


Q: Has Hyospan been studied for use during menstruation?

A: Yes, some regulatory bodies have indicated that Hyospan (hyoscine butylbromide) is specifically recommended or indicated for the treatment of pain associated with menstrual cramps (dysmenorrhea) in certain countries.


Q: Is Hyospan available without a prescription in some countries?

A: The availability status of Hyospan can differ based on local regulatory decisions. However, the oral tablet form of hyoscine butylbromide is frequently categorized as an over-the-counter medicine and can be purchased without a prescription in many regions.


Q: What is the shelf life of Hyospan tablets?

A: Official product data sheets for the tablets specify the shelf life. It is typically documented as 36 months (three years) from the date of manufacture, provided the product is stored according to the official instructions.


Q: Why does Hyospan sometimes cause constipation?

A: Constipation is listed as a potential side effect in some official regulatory documents. The effect is related to the medicine’s action of relaxing the smooth muscles in the gut, which can slow down the natural movement of the bowels.


Q: Can Hyospan be crushed or split?

A: Official guidance on how to administer the tablet form specifies that Hyospan tablets must be swallowed whole with water. The instructions explicitly state that tablets are not to be crushed, broken, or chewed.


Q: Why is Hyospan sometimes given as an injection?

A: The injection form of Hyospan is used in clinical environments for managing acute episodes of severe pain and spasm. This route is chosen, such as for biliary or renal colic, to ensure a rapid onset of the medicine's effect.


Q: Are there different strengths of Hyospan tablets?

A: Yes, official product documents confirm that Hyoscine Butylbromide tablets are commonly manufactured and available in at least two different strengths: 10 mg and 20 mg.


Q: Does Hyospan contain any lactose or gluten?

A: Official product data sheets, which list all inactive ingredients (excipients), confirm that the tablets typically contain sucrose and/or lactose. If there are concerns about excipients such as gluten, official product information should be consulted for the specific formulation.


Q: Can Hyospan affect the results of other medical tests?

A: While regulatory labeling does not provide a definitive list of affected tests, the use of Hyospan can cause short-term physiological changes. For example, the anticholinergic action may result in a temporary tachycardia (increased heart rate), which could temporarily impact certain medical assessments.


Q: Does Hyospan have sedative properties?

A: The primary mechanism of action is peripheral, meaning it does not usually affect the brain. However, information regarding overdose in some regulatory documents notes that mild effects such as slight drowsiness or mild sedative effects have been observed in some cases.


Q: Are there generic versions of Hyospan available?

A: Yes, the active ingredient hyoscine butylbromide is frequently available from multiple manufacturers under different product names. Regulatory listings confirm that generic versions are available in addition to the original brand name.


Q: Can Hyospan be taken with antacids?

A: Official guidance advises that the medicine should be taken separately from antacids. Specifically, it is recommended that Hyospan be administered at least one hour before taking antacids.


Q: Is Hyospan a treatment for long-term chronic pain?

A: Official labeling specifies that Hyospan is intended for short-term or intermittent use to manage spasms. The medicine is not to be used on a continuous daily basis unless the cause of the pain has been medically investigated.

How should Hyospan be stored and disposed of?

How to Store and Dispose of Hyospan?

The storage and disposal of Hyospan (hyoscine butyl bromide) must adhere strictly to officially documented regulatory requirements to ensure product stability and safety.

Storage Requirements

Condition Requirement
Temperature Oral forms must be stored at temperatures not exceeding 30 C. The injection solution requires storage at Controlled Room Temperature (15 C to 30 C).
Protection The product must be protected from light and kept in its original container or outer carton until use.
Prohibition Do not refrigerate or freeze the medicine.
Safety Hyospan must be kept out of the sight and reach of children.

Disposal Instructions

Official labeling states that the medicine must not be disposed of via wastewater or ordinary household waste. Users are instructed to consult a pharmacist for guidance on how to properly discard any unused or expired Hyospan according to local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hyospan found in:

A-Z Index: